Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander W Rankin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Med (New York, N.Y.)|June 15, 2024
CD19 CAR T cells for multiple sclerosis: Forging further into the new frontierAlexander W Rankin, Nirali N Shah
Expert Review of Clinical Immunology|May 13, 2024
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapyAlexandra Dreyzin, Alexander W Rankin, Katia Luciani, et al.
Cancer Metastasis Reviews|December 14, 2024
Evolving strategies for addressing CAR T-cell toxicitiesAlexander W Rankin, Brynn B Duncan, Cecily Allen, et al.
Molecular Therapy. Oncology|February 20, 2026
Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemiasAlexander W Rankin, Amy K Keating, Rolla F Abu-Arja, et al.
Journal for Immunotherapy of Cancer|November 14, 2025
Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survivalAlexander W Rankin, Catherine Pham-Danis, Amanda J Novak, et al.
The Journal of Pediatrics|May 23, 2022
Trametinib for Refractory Chylous Effusions and Systemic Complications in Children with Noonan SyndromeTaizo A Nakano, Alexander W Rankin, Aparna Annam, et al.
Blood Advances|February 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort reviewAlexander W Rankin, Regina M Myers, Adam J Lamble, et al.
Journal for Immunotherapy of Cancer|June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial resultsSara K Silbert, Flavia Gava, Bonnie Yates, et al.
Blood|April 7, 2025
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara K Silbert, Alexander W Rankin, Chloe N Hoang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Med (New York, N.Y.)|June 15, 2024
CD19 CAR T cells for multiple sclerosis: Forging further into the new frontierAlexander W Rankin, Nirali N Shah
Expert Review of Clinical Immunology|May 13, 2024
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapyAlexandra Dreyzin, Alexander W Rankin, Katia Luciani, et al.
Cancer Metastasis Reviews|December 14, 2024
Evolving strategies for addressing CAR T-cell toxicitiesAlexander W Rankin, Brynn B Duncan, Cecily Allen, et al.
Molecular Therapy. Oncology|February 20, 2026
Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemiasAlexander W Rankin, Amy K Keating, Rolla F Abu-Arja, et al.
Journal for Immunotherapy of Cancer|November 14, 2025
Increased NFAT activity with dual CAR stimulation in CD19xCD22 CAR T-cells is associated with decreased exhaustion and improved survivalAlexander W Rankin, Catherine Pham-Danis, Amanda J Novak, et al.
The Journal of Pediatrics|May 23, 2022
Trametinib for Refractory Chylous Effusions and Systemic Complications in Children with Noonan SyndromeTaizo A Nakano, Alexander W Rankin, Aparna Annam, et al.
Blood Advances|February 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort reviewAlexander W Rankin, Regina M Myers, Adam J Lamble, et al.
Journal for Immunotherapy of Cancer|June 5, 2026
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial resultsSara K Silbert, Flavia Gava, Bonnie Yates, et al.
Blood|April 7, 2025
Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemiaSara K Silbert, Alexander W Rankin, Chloe N Hoang, et al.
Pageof 1